Joseph L Hooley Receives Stock Award at Idexx Laboratories Inc DE (IDXX) — SEC Form 4, Nov 03, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
373 sh
325 → 373
Equity Change
+14.8%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Joseph L Hooley CIK 0001123847 |
Director
|
Joseph L Hooley at Idexx Laboratories Inc DE
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Idexx Laboratories Inc DE
| 2026-08-03 | Award | — | View |
| 2026-05-14 | Award | — | View |
| 2026-05-11 | Exercise | — | View |
| 2026-05-04 | Award | — | View |
| 2026-02-03 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-10-30 | A - Award/Grant | 48 A | $551.21 | +$26,458 | 373 | Direct |
Footnotes (1)
- F1
- Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the 'Plan') in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($26,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan. Show more
Related filings at Idexx Laboratories Inc DE
Institutional Holders
13F holders · Jun 30, 2026
1,310
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $4.3B
- Vanguard Capital Management Llc $2.71B
- Vanguard Portfolio Management Llc $2.05B
5%+ Holders · 13D/G
3 filers
Other insiders at Idexx Laboratories Inc DE
GET /v1/forms/4/0000874716-26-000137
API docs
View Original SEC Filing